Đang chuẩn bị liên kết để tải về tài liệu:
Prognostic significance of BRAF and NRAS mutations in melanoma: A German study from routine care

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

: Hotspot mutations of the oncogenes BRAF and NRAS are the most common genetic alterations in cutaneous melanoma. Specific inhibitors of BRAF and MEK have shown significant survival benefits in large phase III trials. However, the prognostic significance of BRAF and NRAS mutations outside of clinical trials remains unclear. | Prognostic significance of BRAF and NRAS mutations in melanoma A German study from routine care

TÀI LIỆU LIÊN QUAN

The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer

Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers

The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: A large retrospective study from Southern China

The prognostic significance of age in operated and non-operated colorectal cancer

Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: A retrospective study

Contrast enhanced computed tomography is indicative for angiogenesis pattern and display prognostic significance in breast cancer

Characteristics of platelet indices and their prognostic significance in selected medical condition – a systematic review

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy

Prognostic Significance of Dyspnea in Patients Referred for Cardiac Stress Testing

Prognostic significance of high-mobility group box protein 1 genetic polymorphisms in rheumatoid arthritis disease outcome
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.